Castleview Partners’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-36
Closed -$3.34K 731
2024
Q2
$3.34K Hold
36
﹤0.01% 671
2024
Q1
$3.35K Hold
36
﹤0.01% 688
2023
Q4
$3.12K Hold
36
﹤0.01% 646
2023
Q3
$2.97K Hold
36
﹤0.01% 528
2023
Q2
$3.06K Hold
36
﹤0.01% 554
2023
Q1
$3K Hold
36
﹤0.01% 544
2022
Q4
$3.06K Hold
36
﹤0.01% 491
2022
Q3
$3K Sell
36
-5,000
-99% -$404K ﹤0.01% 498
2022
Q2
$578K Buy
5,036
+5,000
+13,889% +$418K 0.46% 44
2022
Q1
$3K Sell
36
-3,216
-99% -$272K ﹤0.01% 616
2021
Q4
$36 Buy
+3,252
New +$281K ﹤0.01% 911
2021
Q2
$3K Buy
+36
New +$2.91K ﹤0.01% 834

Other funds holding IXJ

Castleview Partners's IXJ Position: Q3 2024 in Review

Castleview Partners sold out of iShares Global Healthcare ETF (IXJ) in Q3 2024, closing a stake of 36 shares — an estimated $3.34K sold.

Castleview Partners first reported a position in IXJ in Q2 2021 and held it in 12 quarters. The position peaked at $578K in Q2 2022. 273 funds tracked by Wall St. Rank hold IXJ as of Q3 2024.

  • Castleview Partners reported no remaining iShares Global Healthcare ETF position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 36 iShares Global Healthcare ETF shares in Q3 2024, an estimated $3.34K.
  • Castleview Partners first reported a position in iShares Global Healthcare ETF in Q2 2021 and held it in 12 quarters.
  • Castleview Partners's iShares Global Healthcare ETF position peaked at $578K in Q2 2022.
  • 273 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.